Pharmaceutical

Cellectis to focus on CAR-T cell therapies in 2023

Cellectis provided updates for the three CAR-T cell therapies trials, with the three trials recruiting across various cancer indications.

Aug 4, 2023 - 20:00
Cellectis to focus on CAR-T cell therapies in 2023
Cellectis provided updates for the three CAR-T cell therapies trials, with the three trials recruiting across various cancer indications.
Read the original article

Tags:

Previous Article

Accord gears up to commercialise Hipra’s Covid-19 vaccine in the UK

Next Article

Gilead reports 8.45% dip in net income for Q2 2023

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

3M Health receives grant to develop wound treatment solutions in US

3M Health receives grant to develop wound treatment sol...

Jan 11, 2024

Beacon secures $170m to advance ophthalmic gene therapies

Beacon secures $170m to advance ophthalmic gene therapies

Jul 4, 2024

Bavarian Nordic expands access to mpox vaccine in US

Bavarian Nordic expands access to mpox vaccine in US

Apr 3, 2024